ADVENT Income Statement - TTM - Advent Pharma Ltd.

Income Statement (TTM)

Advent Pharma Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	492	464	445	504	504	507	526	530	542	548	552	558	558	564	569	572	522	506	479
Change (%)		-5.77	-4.05	13.10	-0.01	0.72	3.77	0.79	2.26	1.01	0.78	1.05	0.06	0.98	0.87	0.51	-8.68	-3.11	-5.31
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	291	271	253	288	291	300	307	310	319	322	328	335	339	344	348	344	320	314	301
Change (%)		-6.78	-6.93	14.00	1.07	3.06	2.33	1.09	2.67	1.06	1.74	2.31	1.28	1.35	1.26	-1.31	-7.00	-1.74	-4.22
% of Revenue	59.13	58.50	56.74	57.19	57.80	59.15	58.33	58.50	58.74	58.76	59.32	60.06	60.79	61.01	61.24	60.13	61.24	62.10	62.82

Gross Operating Profit	201	193	193	216	212	207	219	220	224	226	225	223	219	220	220	228	202	192	178
Change (%)		-4.32	0.01	11.93	-1.45	-2.48	5.86	0.38	1.67	0.95	-0.59	-0.77	-1.77	0.40	0.27	3.39	-11.21	-5.27	-7.10
% of Revenue	40.87	41.50	43.26	42.81	42.20	40.85	41.67	41.50	41.26	41.24	40.68	39.94	39.21	38.99	38.76	39.87	38.76	37.90	37.18

SG&A	67	62	61	79	83	88	92	87	87	88	87	88	90	92	91	86	83	83	82
Change (%)		-6.78	-2.37	29.96	4.20	6.58	4.12	-5.23	0.55	0.81	-0.67	0.20	3.04	1.80	-0.59	-5.52	-4.04	0.31	-1.03
% of Revenue	13.60	13.45	13.68	15.72	16.39	17.34	17.40	16.36	16.09	16.05	15.82	15.69	16.16	16.29	16.05	15.09	15.85	16.41	17.16

R&D
Change (%)
% of Revenue

OpEx	358	334	314	367	374	388	399	397	406	410	415	423	430	436	440	430	402	397	383
Change (%)		-6.78	-6.07	17.10	1.74	3.84	2.73	-0.36	2.21	1.00	1.23	1.86	1.65	1.44	0.87	-2.19	-6.41	-1.32	-3.56
% of Revenue	72.72	71.95	70.42	72.91	74.19	76.49	75.72	74.86	74.82	74.81	75.14	75.74	76.94	77.30	77.30	75.22	77.09	78.52	79.98

Operating Income	134	130	132	136	130	119	128	133	137	138	137	135	129	128	129	142	120	109	96
Change (%)		-3.09	1.16	3.59	-4.73	-8.24	7.14	4.39	2.40	1.04	-0.53	-1.39	-4.89	-0.57	0.88	9.69	-15.57	-9.13	-11.74
% of Revenue	27.28	28.05	29.58	27.09	25.81	23.51	24.28	25.14	25.18	25.19	24.86	24.26	23.06	22.70	22.70	24.78	22.91	21.48	20.02

Interest Expense	-4	-5	-5	-5	-4	-4	-4	-4	-5	-5	-6	-7	-7	-8	-8	-8	-8	-8	-8
Change (%)		1.89	0.53	6.46	-9.19	-5.55	-2.36	0.13	17.18	14.08	7.24	12.62	2.93	16.56	3.47	-1.65	4.91	-4.97	-1.84
% of Revenue	-0.91	-0.99	-1.03	-0.97	-0.88	-0.83	-0.78	-0.77	-0.89	-1.00	-1.07	-1.19	-1.22	-1.41	-1.45	-1.42	-1.63	-1.60	-1.65

Net Income	98	94	94	114	116	104	110	98	99	99	98	99	93	92	92	84	67	58	49
Change (%)		-4.14	0.29	20.27	2.47	-11.04	6.44	-11.51	1.32	0.58	-0.94	0.18	-5.53	-1.57	0.74	-9.09	-20.69	-12.25	-16.71
% of Revenue	19.95	20.29	21.21	22.56	23.12	20.42	20.94	18.39	18.22	18.14	17.83	17.68	16.69	16.27	16.24	14.69	12.76	11.56	10.16

Source: Capital IQ

Advent Pharma Ltd. - Income Statement (TTM)

Income Statement (TTM)